Adaptive Nutzenbewertung für Untersuchungs- und Behandlungsmethoden mit Medizinprodukten hoher Klassen Die Abwägung von Patientennutzen, Evidenz und Zugang
The GKV-VSG introduced for the first time the benefit assessment of examination and treatment methods with medical devices of high classes and invasive character. In the future, the decision on reimbursement will depend on the documentation of benefits and harm. Basically, the benefit assessment can...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Electronic Book Chapter |
| Published: |
Berlin
MWV Medizinisch Wissenschaftliche Verlagsgesellschaft
2016
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_27122 | ||
| 005 | 20210210 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20210210s2016 xx |||||o ||| 0|deu d | ||
| 020 | |a 9783954664597 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.32745/9783954664597 |c doi | |
| 041 | 0 | |a deu | |
| 042 | |a dc | ||
| 072 | 7 | |a MBN |2 bicssc | |
| 100 | 1 | |a Mühlbacher, Axel |4 auth | |
| 700 | 1 | |a Juhnke, Christin |4 auth | |
| 245 | 1 | 0 | |a Adaptive Nutzenbewertung für Untersuchungs- und Behandlungsmethoden mit Medizinprodukten hoher Klassen |b Die Abwägung von Patientennutzen, Evidenz und Zugang |
| 260 | |a Berlin |b MWV Medizinisch Wissenschaftliche Verlagsgesellschaft |c 2016 | ||
| 300 | |a 1 electronic resource (100 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a The GKV-VSG introduced for the first time the benefit assessment of examination and treatment methods with medical devices of high classes and invasive character. In the future, the decision on reimbursement will depend on the documentation of benefits and harm. Basically, the benefit assessment can be divided into three phases: measuring the causal effects of an intervention, evaluating the measured effects and deciding on the reimbursement of an aggregate overall benefit. In order to meet the requirements, adaptive study designs, the multi-criteria decision analysis and the adaptive benefit assessment represent a future-proof concept for quick access for patients to innovative treatment methods with high quality and safety. | ||
| 540 | |a Creative Commons |f by-nc-nd/4.0 |2 cc |4 http://creativecommons.org/licenses/by-nc-nd/4.0 | ||
| 546 | |a German | ||
| 650 | 7 | |a Public health & preventive medicine |2 bicssc | |
| 653 | |a assessment of benefit | ||
| 653 | |a study design | ||
| 653 | |a decision analysis | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://library.oapen.org/bitstream/20.500.12657/39700/1/adaptive-nutzenbewertung-fur-untersuchungs-und-behandlungsmethoden-mit-medizinprodukten-hoher-klassen.pdf |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/27122 |7 0 |z DOAB: description of the publication |